Skip to main content
42nd ISSTD Annual Conference Main banner
Final Program


Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Jeffrey R. Guss, MD (he/him/his)

Clinical Assistant Professor
NYU School of Medicine
New York, New York, United States

Jeffrey Guss, MD is a psychiatrist, psychoanalyst, researcher and teacher with an interest in the integration of psychoanalytic therapy and psychedelic therapy. He is Clinical Assistant Professor of Psychiatry at the New York University Langone School of Medicine and was Co-Principal Investigator and Director of Psychedelic Psychotherapy for the NYU Psilocybin Cancer Anxiety Research Project. He has been a study therapist with numerous clinical trials of psychedelic therapy, including Psilocybin-Assisted treatment of Major Depressive Disorder, Psilocybin Assisted therapy for Alcohol Use Disorder and MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder.
Dr. Guss is on the faculty of the NYU Postdoctoral Program in Psychotherapy and Psychoanalysis and has published on the topics of gender and sexuality in Psychoanalysis Culture and Society. He is Lead Trainer and Director of the Psychoanalytic Psychedelic
Therapy Program Fluence Continuing Education for Psychedelic Psychotherapy. He lectures on Acceptance and Commitment Therapy, the intersection of psychoanalysis and psychedelic therapy, teaches Clinical Consultation groups , and provides Continuing Case Conferences on Ketamine Assisted Psychotherapy. He has over 22 publications related to the use of Psychedelic Medicines and lectures internationally on Psychoanalysis and Psychedelic Assisted Psychotherapy. An area of active interest is questioning the narratives around intoxication and dissociation in contemporary psychiatric and psychoanalytic discourse. He has recently published “A Psychoanalytic Perspective on Psychedelic Experience” in Psychoanalytic Dialogues in 2022, and published, with Torsten Passie and Rainer Krahnemann, " Lower-dose psycholytic therapy - A Aeglected Approach" in Frontiers in Psychiatry, describing the history of psychedelic therapy within psychiatry and psychoanalysis.
He maintains a private practice of psychotherapy and psychoanalysis, and includes Ketamine Psycholytic Therapy as part of several of these ongoing psychotherapy/psychoanalysis treatments, in New York City.

Disclosure information not submitted.

Presentation(s):